Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/ACTRN12612001277831
ACTRN12612001277831Completed未知

Metformin and dietary advice compared with dietary advice alone in overweight or obese pregnant women to restrict gestational weight gain and reduce the risk of infants being born above 4.0 kg.

The University of Adelaide0 sites524 target enrollmentStarted: December 10, 2012Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
524
Study OverviewStudy DesignEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Prevention
Masking
Blinded (masking used)

Eligibility Criteria

Ages
16 Years to 50 Years (—)
Sex
Female

Inclusion Criteria

  • •Women with a singleton, live gestation between 10 +0 and 20 +0 weeks gestation with a BMI above or equal to 25 kg/m2 at their first antenatal visit.

Exclusion Criteria

  • •Women with a multiple pregnancy, type 1 or 2 diabetes diagnosed prior to pregnancy, known renal or hepatic failure.

Investigators

Similar Trials

Suspended
Phase 1
A Randomised Double-Blind Controlled Trial of Metformin and Atorvastatin – with treatment commenced following prostatic biopsy and ceasing just before radical prostatectomy - to guide subsequent patient managementCancer - ProstateProstate cancer
ACTRN12615000571572niversity of Queensland Centre for Clinical Research80
Recruiting
Phase 3
Effect of using metformin on the incidence of gestational diabetes and preeclampsia in pregnant women with polycystic ovaryPre-eclampsia
IRCT20120215009014N252Hamedan University of Medical Sciences170
Recruiting
Phase 3
empagliflozin effect in polycystic ovarian syndromPolycystic ovarian syndrome.Polycystic ovarian syndromeE28.2
IRCT20220822055771N1Shahre-kord University of Medical Sciences50
Recruiting
Phase 4
A clinical trial involving patients with Polycystic Ovary Syndrome and to compare the effectivess of Metformin and oral contraceptives given alone or in combination to these patients.
CTRI/2019/06/019879SMHS Hospital Srinagar
Active, not recruiting
Not Applicable
Effects of the treatment with metformin and/or sitagliptin on ß- cell function and insulin resistance in women with prior gestational diabetes. - NDprevious gestational diabetesMedDRA version: 9.1Level: LLTClassification code 10000137MedDRA version: 9.1Level: LLTClassification code 10056997
EUCTR2008-003803-30-ITAZIENDA OSPEDALIERA PISANA